The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information: (link sends e-mail)

Study Name on (link is external)
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Study DrugInhaled mannitol
Type of Study DrugRestore Airway Surface Liquid
Study TitleLong Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Study Phase3
Study SponsorPharmaxis

Link on (link is external) (link is external)

Participating ECFS-CTN sitesBelgium: Leuven
France: Bordeaux, Toulouse, Reims, Strasbourg, Lyon, Marseille, Montpellier, Rennes, West-Paris (Cochin) 
Italy: Rome, Verona
Age18 Years and older